See more : UMH Properties, Inc. (UMH-PD) Income Statement Analysis – Financial Results
Complete financial analysis of Diamond Biotechnology Co., Ltd (6815.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Diamond Biotechnology Co., Ltd, a leading company in the None industry within the None sector.
You may be interested
- Gannett Co Inc (NWDVW) Income Statement Analysis – Financial Results
- Stream Ideas Group Limited (8401.HK) Income Statement Analysis – Financial Results
- Gaona Aero Material Co., Ltd. (300034.SZ) Income Statement Analysis – Financial Results
- Pandora A/S (PNDORA.CO) Income Statement Analysis – Financial Results
- Schneider National, Inc. (SNDR) Income Statement Analysis – Financial Results
Diamond Biotechnology Co., Ltd (6815.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 616.10M | 434.84M | 395.20M | 306.39M | 268.35M |
| Cost of Revenue | 326.50M | 250.53M | 207.32M | 177.96M | 133.59M |
| Gross Profit | 289.59M | 184.32M | 187.88M | 128.43M | 134.77M |
| Gross Profit Ratio | 47.00% | 42.39% | 47.54% | 41.92% | 50.22% |
| Research & Development | 29.33M | 25.94M | 27.93M | 2.89M | 1.12M |
| General & Administrative | 54.75M | 47.20M | 41.64M | 34.19M | 36.44M |
| Selling & Marketing | 140.14M | 64.11M | 70.23M | 77.95M | 39.81M |
| SG&A | 194.89M | 111.31M | 111.86M | 112.14M | 77.35M |
| Other Expenses | 0.00 | -1.09M | 6.40M | 944.00K | 0.00 |
| Operating Expenses | 225.69M | 137.25M | 139.79M | 115.03M | 77.12M |
| Cost & Expenses | 552.19M | 387.78M | 347.11M | 293.00M | 210.70M |
| Interest Income | 696.00K | 429.00K | 44.00K | 53.00K | 29.00K |
| Interest Expense | 7.52M | 3.74M | 2.27M | 2.48M | 1.13M |
| Depreciation & Amortization | 50.32M | 53.48M | 58.18M | 54.82M | 22.77M |
| EBITDA | 116.17M | 99.89M | 112.72M | 69.21M | 79.07M |
| EBITDA Ratio | 18.86% | 22.97% | 28.52% | 22.59% | 29.47% |
| Operating Income | 65.37M | 46.41M | 54.54M | 14.39M | 56.30M |
| Operating Income Ratio | 10.61% | 10.67% | 13.80% | 4.70% | 20.98% |
| Total Other Income/Expenses | -7.04M | -4.40M | 4.17M | -1.48M | 246.00K |
| Income Before Tax | 58.33M | 41.82M | 52.05M | 13.51M | 56.55M |
| Income Before Tax Ratio | 9.47% | 9.62% | 13.17% | 4.41% | 21.07% |
| Income Tax Expense | 11.59M | 8.44M | 10.13M | 2.46M | 12.36M |
| Net Income | 46.74M | 33.39M | 41.92M | 11.05M | 44.18M |
| Net Income Ratio | 7.59% | 7.68% | 10.61% | 3.61% | 16.46% |
| EPS | 1.50 | 1.20 | 1.51 | 0.41 | 1.93 |
| EPS Diluted | 1.50 | 1.20 | 1.51 | 0.41 | 1.92 |
| Weighted Avg Shares Out | 31.25M | 27.82M | 27.82M | 26.93M | 22.89M |
| Weighted Avg Shares Out (Dil) | 31.26M | 27.83M | 27.83M | 26.93M | 22.98M |
No news found for: 6815.TWO
Source: https://incomestatements.info
Category: Stock Reports